申请人:MITSUBISHI TANABE PHARMA CORPORATION
公开号:US20150158844A1
公开(公告)日:2015-06-11
The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR
1
or nitrogen atom; R
1
is hydrogen and the like; R
2
is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.